Stock of the day: CSL
CSL and WiseTech Global show resilience during recent market turbulence. Both companies maintain strong fundamentals that may outweigh short-term market noise.
(AI video summary)
This video was created on 11 April for IG audiences by ausbiz.
ASX code: CSL
CSL's market position and growth prospects
CSL has seen a significant stock price decline due to fears around potential pharmaceutical tariffs, though analysts maintain price targets of $320-$330. Commanding 30-40% of the global blood plasma market, CSL benefits from strong pricing power as healthcare products fulfill essential needs rather than wants. The company shows robust financials with nearly 20% net margins and projected 12% revenue growth. Its diversified production across Switzerland, Melbourne and other locations reduces vulnerability to single-market tariff exposure.
WiseTech Global's strategic positioning
WiseTech Global has shown remarkable resilience, finishing up during a recent session despite the US Tech 100 falling 9-10%. Its CargoWise platform, used by major freight forwarders, could benefit from increasing trade complexity as new tariffs create opportunities for expanded product offerings.
Investment considerations in volatile markets
Both companies represent quality businesses with strong fundamentals. For CSL, concerns about its Seqirus vaccine division appear overstated, while its global presence helps mitigate regional risks. Investors should focus on these companies' underlying business models and growth prospects beyond short-term market noise.
News and trade ideas
Gold
-
Trade of the week: stand aside
This week's trade recommendation focuses on risk management and the strategic value of not trading during turbulent conditions.Commodities -
-
-
This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.
Explore the markets with our free course
Learn how shares work – and discover the wide range of markets you can trade on – with IG Academy's free ’introducing the financial markets’ course.
Put learning into action
Try out what you’ve learned in this shares strategy article risk-free in your demo account.
Ready to trade shares?
Put the lessons in this article to use in a live account – upgrading is quick and easy.
- Trade over 16,000 popular global stocks
- Protect your capital with risk management tools
- React to breaking news with out-of-hours trading on 70 key US stocks
Inspired to trade?
Put your new knowledge into practice. Log in to your account now.
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
